Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Odd Terje BrustugunSteinar Kristian Solberg

Abstract

There have been significant changes in both diagnostic procedures and therapy for lung cancer since the beginning of the millennium. National incidence and survival data from 2000 through 2016 are studied. National data on cancer incidence and vital status are virtually complete. Changes in incidence and survival are described by absolute numbers, percentages, and calculation of relative survival (period analysis). A total of 44,825 individuals were diagnosed with lung cancer in Norway in the study period. The number of incident cases increased with 49% whereas the prevalence increased with 136% from 2000 to 2016. Age-standardised rates rose markedly for women and levelled off for men. In 2016, adenocarcinoma accounted for about 50% of all lung cancers, slightly more for women than for men. The entity "NSCLC not otherwise specified" declined from 24% to 13%, and the fraction of patients with metastatic disease decreased from 54% to 46% during the period, for both sexes combined. The overall median survival time doubled for women and men, reaching 14.3 months and 11.4 months, respectively. For patients with metastatic disease, median survival time showed a small increase but remained less than 6 months. The overall 5-year relati...Continue Reading

References

Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hermann Brenner, Bernard Rachet
Jun 28, 2007·British Journal of Cancer·N HelbekkmoUNKNOWN Norwegian Lung Cancer Study Group
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Inger Kristin LarsenBjørn Møller
Oct 23, 2010·Cancer Causes & Control : CCC·David M BurnsNigel Gray
Nov 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David PalmaSuresh Senan
Jun 22, 2011·Biometrics·Maja Pohar PermeJacques Estève
May 9, 2012·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Odd Terje BrustugunLars Helgeland
Jul 2, 2014·British Journal of Cancer·O T BrustugunA Helland
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 20, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Larissa SchwarzkopfRudolf Maria Huber
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 1, 2015·International Journal of Cancer. Journal International Du Cancer·Yngvar NilssenBjørn Møller
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvia FrancisciUNKNOWN EUROCARE-5 Working Group:
Nov 7, 2015·The European Respiratory Journal·Y NilssenB Møller
Oct 27, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jan NymanIngmar Lax
Nov 29, 2016·Acta Oncologica·O T BrustugunÅ Helland
Apr 19, 2017·Acta Oncologica·Niels Lyhne ChristensenTorben Riis Rasmussen
May 10, 2017·The Journal of Thoracic and Cardiovascular Surgery·Timothy L McMurryBenjamin D Kozower
Jun 20, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Elisabeth J DriessenMaryska L Janssen-Heijnen
Sep 28, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Matthew J BoyerJoseph K Salama
Nov 7, 2017·The Annals of Thoracic Surgery·Nirav S KapadiaFeng Ming Kong

❮ Previous
Next ❯

Citations

Jul 18, 2019·European Journal of Epidemiology·Steinar SolbergLars Fjellbirkeland
Aug 29, 2019·Frontiers in Pharmacology·Mathie NajbergEmmanuel Garcion
Aug 7, 2019·Journal of Cachexia, Sarcopenia and Muscle·Bjørn H GrønbergMarit S Jordhøy
Sep 16, 2020·Acta Oncologica·Kirsti V HjerkindGiske Ursin
Oct 8, 2020·Nature Reviews. Cancer·Christoph A Klein
Dec 11, 2021·Acta Oncologica·Lukas LöflingGunnar Wagenius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
M SantRiccardo Capocaccia
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Giorgio Scagliotti, Silvia Novello
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
S KariE Läärä
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
C LepageEUROCARE-5 Working Group:
© 2022 Meta ULC. All rights reserved